TuHURA Biosciences, Inc.
HURA
$2.01
-$0.11-5.19%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -22.38% | -11.47% | 4.80% | 25.42% | -42.91% |
| Total Depreciation and Amortization | 19.57% | 4.44% | 5.63% | 58.96% | -4.96% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -23.35% | 1,060.73% | -87.62% | 38.32% | -1.24% |
| Change in Net Operating Assets | -717.60% | -34.01% | 107.74% | -420.78% | 280.81% |
| Cash from Operations | -95.64% | 20.57% | 49.88% | -77.44% | -31.86% |
| Capital Expenditure | -180.74% | -74.91% | -- | 100.00% | 86.89% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | 100.00% | 86.39% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -180.74% | -74.91% | -- | 100.00% | 86.40% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 94.67% | 88.48% | -213.50% | -- | -- |
| Issuance of Common Stock | -95.85% | 21.14% | -0.10% | -31.38% | 1,691.17% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Other Financing Activities | -186.91% | 82.91% | -151.72% | -5.01% | 68.44% |
| Cash from Financing | -51.42% | 9.74% | 23.44% | -39.40% | 1,687.44% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -297.98% | 190.32% | 115.86% | -353.62% | 135.62% |